Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study
Condition(s):Uveitis, Posterior; Uveitis, Anterior; Uveitis, Intermediate; PanuveitisLast Updated:October 16, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Uveitis, Posterior; Uveitis, Anterior; Uveitis, Intermediate; PanuveitisLast Updated:October 16, 2023Recruiting
Condition(s):Non-infectious Intermediate Uveitis; Non-infectious Posterior Uveitis; Non-infectious Pan UveitisLast Updated:July 19, 2023Active, not recruiting
Condition(s):Uveitis, Posterior; Uveitis, Intermediate; PanuveitisLast Updated:December 16, 2022Recruiting
Condition(s):Uveitis, Posterior; Uveitis, Intermediate; PanuveitisLast Updated:August 3, 2021Terminated
Condition(s):Uveitis; Uveitis, Posterior; Uveitis, Anterior; Uveitis, Intermediate; PanuveitisLast Updated:June 23, 2021Completed
Condition(s):Uveitis; Uveitis, Posterior; Uveitis, Anterior; Uveitis, Intermediate; PanuveitisLast Updated:June 2, 2021Completed
Condition(s):Posterior Uveitis; Intermediate Uveitis; PanuveitisLast Updated:July 21, 2020Completed
Condition(s):Uveitis; Intermediate Uveitis; Posterior Uveitis; Panuveitis; Noninfectious UveitisLast Updated:February 21, 2021Completed
Condition(s):Intermediate Uveitis; Posterior Uveitis; Pan-uveitisLast Updated:April 28, 2017Unknown status
Condition(s):Non-infectious Intermediate Uveitis; Non-infectious Posterior Uveitis; Non-infectious PanuveitisLast Updated:January 5, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.